TAG:
laboratories
LAB-Interlink Clients Experience Highs & Lows
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: It was right before Thanksgiving weekend when LAB-Interlink laid off most of its staff and was left with a skeleton crew. Since that date, at least one major laboratory customer was unable to get needed service and parts, causing a total shutdown of its automated line. Howeve…
Web Lab Test Ordering Market Is Increasing
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: In recent years, the market for browser-based laboratory test ordering and results reporting systems has grown at a steady rate. Second and third generation products are more robust, offer more features, and are easier to install and operate. To date, smaller start-up compani…
More Firms Now Offer Web Lab Info Products
By Robert Michel | From the Volume XI No. 2 – February 2, 2004 Issue
CEO SUMMARY: Since our last vendor directory in winter 2001, the number of companies selling browser-based systems for laboratory testing ordering and results reporting has doubled! That’s a sign that laboratories recognize the need to have an Internet strategy and are taking steps to d…
Anatomic Path Trends Portend Deep Changes
By Robert Michel | From the Volume XI No. 1 – January 12, 2004 Issue
CEO SUMMARY: Our biannual review of trends shaping the anatomic pathology profession reveals that a wide range of influences are active. The nation’s healthcare system is undergoing fundamental changes in how it views the quality of health services and how it will favor top-performing p…
Offering Molecular Tests Has Surprises & Pitfalls
By Robert Michel | From the Volume XI No. 1 – January 12, 2004 Issue
CEO SUMMARY: Laboratories that offer some of the new assays based on molecular technologies often find themselves facing significant financial risk. That’s because payers are skeptical about new lab tests which come at a high price, but don’t offer substantial clinical benefit. One ea…
RFP Secrets To Use When Buying Molecular Tests
By Robert Michel | From the Volume XI No. 1 – January 12, 2004 Issue
CEO SUMMARY: It often takes two to four years before payer coverage and reimbursement become stable. During that time, NorDx Laboratories wants the vendors who sell it new molecular assays to have some “skin in the game.” It accomplishes this by negotiating contracts that link the con…
“January 12, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 1 – January 12, 2004 Issue
There’s a new joint venture between a commercial laboratory and a multi-hospital group. On January 5, 2004, LabOne, Inc. of Lenexa, Kansas announced that it had completed negotiations with The Health Alliance of Greater Cincinnati. LabOne paid $38.5 millio…
Welcome Back, Consumers!
By Robert Michel | From the Volume X No. 17 – December 22, 2003 Issue
DURING 2003, THERE WAS SURPRISING PROGRESS IN THE MOVEMENT to improve patient safety. Closely-connected to the patient safety trend are efforts to measure and make public the healthcare outcomes achieved by hospitals, physicians, laboratories, and other providers. One reason why this movement is imp…
2003’s Big Lab Stories Reflect Health Trends
By Robert Michel | From the Volume X No. 17 – December 22, 2003 Issue
CEO SUMMARY: At a minimum, 2003 proved to be a year of relative stability for the laboratory industry, as demonstrated by THE DARK REPORT’S “Ten Biggest Lab Stories of 2003.” The year was free of industry-wide crises and scan- dals. That allowed most laboratory administrators and pa…
LabOne Speaks Out About Use of “Free Testing”
By Robert Michel | From the Volume X No. 17 – December 22, 2003 Issue
DEAR EDITOR, In the August 26, 2002 issue of THE DARK REPORT, an article appeared entitled, “Two Blood Brothers Use ‘Free Testing’ Strategy.” In markets that we are “in-network” with various payers, this tactic of providing free testing is increasingly prevalent. While t…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized